Diminished myofibril organization in mutant axolotl hearts transfected with site-directed mutants of sarcomeric tropomyosins

Cardiovascular Toxicology

Volumn 5, Issue 1, 2005, Pages 75-90

  Zajdel, Robert W ^a   Denz, Christopher R ^a   McLean, Matthew D ^a   Dube, Syamalima ^a   Muthuchamy, Mariappan ^b   Poiesz, Bernard J ^a   Wieczorek, David F ^c   Dube, Dipak K ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Gene transfer; Partial disarray; Sarcomere; Site directed mutagenesis; Tropomyosin

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; GLUTAMINE; HYBRID PROTEIN; LIPOSOME; LYSINE; TROPOMYOSIN; TROPOMYOSIN 4ALPHA; UNCLASSIFIED DRUG;

AMBYSTOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HEART; MUSCLE FIBRIL; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE; WESTERN BLOTTING; WILD TYPE;

AMBYSTOMA MEXICANUM;

EID: 18544369423     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/ct:5:1:075     Document Type: Article

References (36)

1. Moore, P.B. and Lemanski, L.F. (1982). Quantitation of tropomyosin by radioimmunoassay in developing hearts of cardiac mutant axolotls, Ambystoma mexicanum. J. Muscle Res. Cell Motil. 3:161-167.
2. Starr, C., Diaz, J.G., and Lemanski, L.F. (1989). Analysis of actin and tropomyosin in hearts of cardiac mutant axolotls by two-dimensional gel electrophoresis, western blots, and immunofluorescent microscopy. J. Morphol. 210: 1-10.
3. Zajdel, R.W., McLean, M.D., Lemanski, S.L., Muthuchamy, M., Wieczorek, D.F., Lemanski, L.F., and Dube, D.K. (1998). Ectopic expression of tropomyosin promotes myofibrillogenesis in mutant axolotl hearts. Dev. Dyn. 213: 412-420.
4. Zajdel, R.W., Dube, D.K., and Lemanski, L.F. (1999). The cardiac mutant Mexican axolotl is a unique animal model for evaluation of cardiac myofibrillogenesis. Exp. Cell Res. 248:557-566.
5. Liu, H. and Bretscher, A. (1989). Disruption of the single tro-pomyosin gene in yeast results in the disappearance of actin cables from the cytoskeleton. Cell 57:233-242.
6. Blanchard, E.M., Iizuka, K., Christe, M., Conner, D.A., Geisterfer-Lowrance, A., Schoen, F.J., et al. (1998). Targeted ablation of the murine alpha-tropomyosin gene. Circ. Res. 81:1005-1010.
7. Rethinasamy, P., Muthuchamy, M., Hewett, T., Boivin, G., Wolska, B.M., Evans, C., et al. (1998). Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ. Res. 82:116-123.
8. Ho, C.Y., Lever, H.M., DeSanctis, R., Farver, C.F., Seidman, J.G., and Seidman, C.E. (2000). Homozygous mutation in cardiac troponin T. Circulation 102:1950-1953.
9. Tardiff, J.C., Factor, S.M., Tompkins, B.D., Hewett, T.E., Palmer, B.M., Moore, R.L., et al. (1998). A truncated troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:2800-2811.
10. Fatkin, D., Christe, M.E., Aristizabal, O., McConnell, B.K., Srinivasan, S., Schoen, F.J., et al. (1999). Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α-cardiac myosin heavy chain gene. J. Clin. Invest. 103:147-153.
11. Nakajima-Taniguchi, C., Matsui, H., Nagata, S., Kishimoto, T., and Yamauchi-Takihara, K. (1995). Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 27:2053-2058.
12. Yamauchi-Takihara, K., Nakajima-Taniguchi, C., Matsui, H., Fujio, Y., Kunisada, K., Nagata, S., and Kishimoto, T. (1996). Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene. Heart 76:63-65.
13. Karibe, A., Tobacman, L.S., Strand, J., Butters, C., Back, N., Bachinski, L.L., et al. (2001). Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103(1):65-71.
14. Coviello, D.A., Maron, B.J., Spirito, P., Watkins, H., Vosberg, H.P., Thierfelder, L., et al. (1997). Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the α-tropomyosin gene. J. Am. Coll. Cardiol. 29:635-640.
15. Jaaskelainen, P., Sorantaa, M., Miettinen, R., Saarinen, L., Pihlajamaki, J., Slivennoinen, K., et al. (1998). The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J. Am. Coll. Cardiol. 32:1709-1716.
16. Thierfelder, L., MacRae, C., Watkins, H., Tomfohrde, J., Williams, M., McKenna, W., et al. (1993). A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc. Natl. Acad. Sci. USA 90:6270-6274.
17. Thierfelder, L., Watkins, H., MacRae, C., Lamas, R., McKenna, W., Vosberg, H.P., et al. (1994). α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701-712.
18. Regitz-Zagrosek, V., Erdmann, J., Wellenhofer, E., Raible, J., and Fleck, E. (2000). Novel mutation inthe α-tropomyosin gene and transition from hypertrophic to hypercontractile dilated cardiomyopathy. Circulation 102:E112-E116.
19. Zot, A.S. and Potter, J.D. (1987). Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Ann. Rev. Biophys. Biophys. Chem. 16:535-559.
20. Golitsina, N., An, Y., Greenfield, N.J., Thierfelder, L., Iizuka, K., Seidman, J.G., et al. (1997). Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry 36:4637-4642.
21. Luque, E.A., Spinner, B.J., Dube, S., Dube, D.K., and Lemanski, L.F. (1997). Differential expression of a novel isoform of alpha-tropomyosin in cardiac and skeletal muscle of the Mexican axolotl (Amby stoma mexicanum). Gene 185:175-185.
22. Narshi, A., Denz, C.R., Nakatsugawa, M., Zajdel, R.W., Dube, S., Poiesz, B.J., and Dube, D.K. (2005). Cardiac myofibril formation is not affected by modification of both N & C-termini of sarcomeric tropomyosin. Cardiovas. Toxicol. 5:1-8.
23. Zajdel, R.W., Denz, C.R., Lee, S., Dube, S., Ehler, E., E. Perriard, E., et al. (2003). Identification, characterization, and expression of a novel α-tropomyosin isoform in cardiac tissues in developing chicken. J. Cell Biochem. 89:427-439.
24. Forry-Schaudies, S., Maihle, N.J., and Hughes, S.H. (1990). Generation of skeletal, smooth, and low molecular weight non-muscle tropomyosin isoforms for the chicken tropomyosin 1 gene. J. Mol. Biol. 211:321-330.
25. Hardy, S., Theze, N., Lepetit, M., Allo, M., and Thiebaud, P. (1995). The Xenopus laevis TM-4 gene encodes non-muscle and cardiac tropomyosin isoforms through alternative splicing. Gene 156:265-270.
26. Michele, D.E., Albayya, F.P., and Metzger, J.M. (1999). Direct convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes. Nature Med. 5:1413-1417.
27. Muthuchamy, M., Grupp, I.L., Grupp, G., O'Toole, B.A., Kier, A.B., Boivin, G.P., et al. (1995). Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J. Biol. Chem. 270:30593-30603.
28. Subramanian, A., Jones, W.K., Gillick, J., Wert, S., Neumann, J., Robbins, J. (1991). Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266:24613-24620.
29. Muthuchamy, M., Pieples, K., Rethinasamy, P., Hoit, B., Grupp, I., Boivin, G.P., et al. (1999). Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction. Circ. Res. 85: 47-56.
30. Ward, S.M., Dube, D.K., Fransen, M.C., and Lemanski, L.F. (1996). Differential expression of C-protein isoforms in the developing heart of normal and cardiac lethal mutant axolotls (Ambystoma mexicanum). Dev. Dyn. 205:93-103.
31. McLachlan, A.D. and Stewart, M. (1975). Tropomyosin coiled-coil interactions: evidence for an unstaggered structure. J. Mol. Biol. 98:293-304.
32. Conway, J.F. and Parry, D.A. (1990). Structural features in the heptad substructure and longer range repeats of two-stranded alpha-fibrous proteins. Int. J. Biol. Macromol. 12:328-334.
33. Hitchcock-DeGregori, S.E. and An, Y. (1996). Integral repeats and a continuous coiled coil are required for binding of striated muscle tropomyosin to the regulated actin filament. J. Biol. Chem. 271:3600-3603.
34. Hernandez, O.M., Housmans, P.R., and Potter, J.D. (2001). Plasticity in skeletal, cardiac, and smooth muscle. Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation. J. Appl. Physiol. 90:1125-1136.
35. Tobacman, L.S., Lin, D., Butters, C., Landis, C., Back, N., Pavlov, D., and Homsher, E. (1999). Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy. J. Biol. Chem. 274:28,363-28,370.
36. Bottinelli, R., Coviello, D.A., Redwood, C.S., Pelligrino, M.A., Maron, B.J., Spirito, P., et al. (1998). A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ. Res. 82:106-115.